* Q4 earnings per share view $-0.70 — Thomson Reuters I/B/E/S Source text for Eikon: (1.usa.gov/1py8DmV) Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
The post BRIEF-Cidara Therapeutics posts Q4 loss per share $0.72 appeared first on NASDAQ.